French medical device company PROTEOR has acquired Filament Innovations, a company specializing in 3D printing technologies for the orthotics and prosthetics (O&P) industry. The acquisition broadens PROTEOR’s digital solutions portfolio to include scanning, rectification, and 3D printing tools, supporting the development of customized medical device solutions.
Man jumping with a 3D prosthesis. Photo PROTEOR.
Filament Innovations: Areas of Focus and Key Collaborations
Filament Innovations operates primarily in two areas: 3D printing technology and printing materials. The company focuses on extrusion-based, high-speed 3D printing with carbon-filled materials. Its ICARUS 3D printer is used in clinical settings for applications such as producing definitive sockets. In addition, the company manufactures a variety of printing materials, including pellets and filaments made from PETG, TPU, and CPX-Kyrion MAX.
In 2024, Filament Innovations collaborated with Dyze Design, a manufacturer of high-performance, pellet-based extrusion systems, to integrate the Aurora motion control system into its platforms. Aurora was developed to streamline professional and industrial 3D printing workflows by generating detailed validation reports and providing more user-friendly interfaces. The system addresses key operational challenges and improves production efficiency for both manufacturers and end users.
Industry-Wide Momentum in Digital O&P Solutions
Manufacturing on Demand
The PROTEOR–Filament Innovations deal is one of several strategic moves in the growing digital O&P sector. In early 2024, Qwadra—the digital arm of Eqwal and a global provider of digital O&P solutions—entered a strategic partnership with Danish company Create it REAL, a developer of advanced 3D printing technologies. The collaboration integrates Create it REAL’s patented Programmable Foam technology into Qwadra’s Sona Flex and Sona Edge 3D printers. The development is intended to enhance the ability of clinicians to produce orthopedic devices with improved precision, speed, and material efficiency.
Earlier, in 2019, PVA—a global supplier of fluid dispensing and conformal coating systems—acquired Create Orthotics & Prosthetics, a New York-based provider of 3D printed O&P devices. The acquisition led to the formation of PVA’s Medical Device Division, expanding the company’s reach beyond electronics assembly into healthcare applications.
W
You might also like:
“Game-changing Milestone” as Lithoz Beta-TCP Implants Show 92% Success in Long-Term Clinical Evaluation: “This first ever long-term clinical follow-up study marks a historic moment for the entire additive manufacturing industry. These results are not only about celebrating a great achievement for our Lithoz LCM technology. By clinically proving a success rate of over 92%, we’ve set a game-changing milestone in the history of surgery to establish the 3D printing of patient-specific bioceramic implants as a fully-fledged alternative alongside traditional surgical interventions,” said Dr. Johannes Homa, CEO of Lithoz.
* This article is reprinted from 3D Printing Industry. If you are involved in infringement, please contact us to delete it.
Author: Paloma Duran
Leave A Comment